HANC: HIV/AIDS Network Coordination

The HIV/AIDS Network Coordination (HANC) project works with the six HIV/AIDS clinical trials networks funded by the Division of AIDS (DAIDS) of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.

Get Involved in HIV/AIDS Clinical Trials

Learn more about participating in a clinical research study or engaging your community in clinical trials research.

HANC Calendar

Check for scientific conferences, network meetings, community events, training dates, etc.

Training Resources

View a variety of training resources including the online HIV Research Counseling and Testing (HRCT) curriculum, HSP and GCP training.

Lab Resources

Find info for labs such as procedures and SOPs.

Legacy Project

Learn how HANC is working to increase participation of African Americans and Hispanics in HIV clinical trials.

HANC is supported by:

Link to US Dept. of Health and Human Services

Find us, follow us, friend us:

Announcements

New Be the Generation Bridge Partners Awarded.

Be the Generation Bridge (BTG Bridge), a National Institute of Allergy and Infectious Diseases (NIAID) funded collaborative effort between FHI 360 and Legacy Project is pleased to announce the newly selected BTG Bridge partners. BTG Bridge awarded 18 local and national organizations identified as being capable of helping meet the goals of the BTG Bridge Partnership Project.

More information

RFAs for the 5 NIAID HIV/AIDS leadership groups are now posted

Deadline for submission is September 28, 2012.

More information

New Job Posting:

The National Institute of Allergy and Infectious Diseases seeks an exceptional and visionary leader to take on the role of director, Office for Policy in Clinical Research Operations (OPCRO) in the Division of AIDS (DAIDS). The OPCRO director serves as a key advisor to the DAIDS director and to scientific programs on all clinical research oversight issues; provides objective, experience-based guidance and oversight; and is responsible for identifying and resolving a variety of complex clinical trials management, policy and administrative issues. Closes January 31, 2012.

More information

MTN to Discontinue Use of Tenofovir Gel in VOICE, A Major HIV Prevention Study in Women.

VOICE, an HIV prevention trial that has been evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women - daily use of one of two different ARV tablets or of a vaginal gel - will be dropping the vaginal gel from the study.

More information